{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:00:07Z","timestamp":1782979207950,"version":"3.54.5"},"reference-count":25,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijn.ijn_293_17","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T08:00:47Z","timestamp":1554710447000},"page":"186","source":"Crossref","is-referenced-by-count":5,"title":["Plasma free homocysteine levels in children with idiopathic nephrotic syndrome"],"prefix":"10.25259","volume":"29","author":[{"given":"Abhijeet","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbity","family":"Deepthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trayambak","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VineetaV","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AshishD","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.255635-1","doi-asserted-by":"crossref","unstructured":"Kniazewska MH, Obuchowicz AK, Wielkoszynski T, Zmudzinska-Kitczak J, Urban K, Marek M, et al. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol 2009;24:549-54","DOI":"10.1007\/s00467-008-1029-1"},{"key":"key-10.4103\/0971-4065.255635-2","doi-asserted-by":"crossref","unstructured":"Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ. The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 2004;9:744-8","DOI":"10.1007\/s00467-004-1460-x"},{"key":"key-10.4103\/0971-4065.255635-3","doi-asserted-by":"crossref","unstructured":"Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999;81:165-76","DOI":"10.1055\/s-0037-1614438"},{"key":"key-10.4103\/0971-4065.255635-4","doi-asserted-by":"crossref","unstructured":"Sharma B, Saha A, Dubey NK, Kapoor K, Anubhuti, Batra VV, et al. Endothelial dysfunction in children with idiopathic nephrotic syndrome. Atherosclerosis 2014;233:704-6","DOI":"10.1016\/j.atherosclerosis.2014.01.055"},{"key":"key-10.4103\/0971-4065.255635-5","doi-asserted-by":"crossref","unstructured":"Welch GN, Loscalzo J. Homocysteine and atherothrombosis N Engl J Med 1998;338:1042-50","DOI":"10.1056\/NEJM199804093381507"},{"key":"key-10.4103\/0971-4065.255635-6","first-page":"1106","volume-title":"Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension","author":"Virdis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-4065.255635-7","first-page":"3","volume-title":"Facts and recommendations about total homocysteine determinations: An expert opinion","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"key-10.4103\/0971-4065.255635-8","doi-asserted-by":"crossref","unstructured":"Ueland PM. Homocysteine species as components of plasma redox thiol status Clin Chem 1995;41:340-2","DOI":"10.1093\/clinchem\/41.3.340"},{"key":"key-10.4103\/0971-4065.255635-9","first-page":"1775","volume-title":"Plasma homocysteine as a risk factor for vascular disease.The European Concerted Action Project","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"key-10.4103\/0971-4065.255635-10","first-page":"877","volume-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"key-10.4103\/0971-4065.255635-11","first-page":"1810","volume-title":"Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?","author":"Bennett-Richards","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/0971-4065.255635-12","doi-asserted-by":"crossref","unstructured":"Kundal M, Saha A, Dubey NK, Kapoor K, Basak T, Bhardwaj G, et al. Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome. Clin Transl Sci 2014;7:132-6","DOI":"10.1111\/cts.12145"},{"key":"key-10.4103\/0971-4065.255635-13","doi-asserted-by":"crossref","unstructured":"Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000;102:2479-83","DOI":"10.1161\/01.CIR.102.20.2479"},{"key":"key-10.4103\/0971-4065.255635-14","doi-asserted-by":"crossref","unstructured":"Chambers JC, Ueland PM, Wright M, Dore CJ, Refsum H, Kooner JS. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ Res 2001;89:187-92","DOI":"10.1161\/hh1401.093459"},{"key":"key-10.4103\/0971-4065.255635-15","doi-asserted-by":"crossref","unstructured":"Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18","DOI":"10.1172\/JCI116187"},{"key":"key-10.4103\/0971-4065.255635-16","doi-asserted-by":"crossref","unstructured":"Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993;13:1327-33","DOI":"10.1161\/01.ATV.13.9.1327"},{"key":"key-10.4103\/0971-4065.255635-17","doi-asserted-by":"crossref","unstructured":"Starkebaum G, Harlan JM: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986:77:1370-6","DOI":"10.1172\/JCI112442"},{"key":"key-10.4103\/0971-4065.255635-18","doi-asserted-by":"crossref","unstructured":"Dudman NP, Temple SE, Guo XW, Fu W, Perry MA. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999;84:409-16","DOI":"10.1161\/01.RES.84.4.409"},{"key":"key-10.4103\/0971-4065.255635-19","first-page":"135","volume-title":"Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome","author":"van","year":"2008","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0971-4065.255635-20","first-page":"203","volume-title":"Management of steroid sensitive nephrotic syndrome: Revised guidelines","author":"Indian","year":"2008","journal-title":"Indian Pediatr"},{"key":"key-10.4103\/0971-4065.255635-21","first-page":"35","volume-title":"Management of steroid resistant nephrotic syndrome","author":"Indian","year":"2009","journal-title":"Indian Pediatr"},{"key":"key-10.4103\/0971-4065.255635-22","unstructured":"Tkaczyk M, Czupryniak A, Nowicki M, Chwatko G, Bald E. Homocysteine and glutathione metabolism in steroid-treated relapse of idiopathic nephrotic syndrome. Pol Merkur Lekarski 2009;26:294-7"},{"key":"key-10.4103\/0971-4065.255635-23","doi-asserted-by":"crossref","unstructured":"Podda GM, Lussana F, Moroni G, Faioni EM, Lombardi R, Fontana G, et al. Abnormalities of homocysteine and B vitamins in the nephrotic syndrome. Thromb Res 2007;120:647-52","DOI":"10.1016\/j.thromres.2006.12.011"},{"key":"key-10.4103\/0971-4065.255635-24","doi-asserted-by":"crossref","unstructured":"Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46","DOI":"10.1146\/annurev.nutr.19.1.217"},{"key":"key-10.4103\/0971-4065.255635-25","doi-asserted-by":"crossref","unstructured":"Upchurch GR, Jr., Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Jr., et al. Homocystiene decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;1272:17012-7.","DOI":"10.1074\/jbc.272.27.17012"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:46:49Z","timestamp":1712173609000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/plasma-free-homocysteine-levels-in-children-with-idiopathic-nephrotic-syndrome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["255635"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_293_17","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}